{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:41:10Z","timestamp":1772851270821,"version":"3.50.1"},"reference-count":202,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.bbmt.2016.09.005","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T12:37:01Z","timestamp":1473770221000},"page":"367-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report"],"prefix":"10.1016","volume":"23","author":[{"given":"Lindsay M.","family":"Morton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"Saber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Scott","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. John","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Engels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahinaz M.","family":"Gadalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda J.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2016.09.005_bib0010","author":"Pasquini"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0015","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","article-title":"Long-term survival and late deaths after allogeneic hematopoietic cell transplantation","volume":"29","author":"Wingard","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0020","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1182\/blood-2005-01-0035","article-title":"Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study","volume":"105","author":"Bhatia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0025","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0030","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.bbmt.2013.07.020","article-title":"Prevalence of hematopoietic cell transplant survivors in the United States","volume":"19","author":"Majhail","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0035","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.bbmt.2011.10.005","article-title":"Subsequent malignant neoplasms after hematopoietic cell transplantation","volume":"18","author":"Socie","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0040","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","article-title":"Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study","volume":"110","author":"Bhatia","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0045","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2009.25.6693","article-title":"Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation","volume":"28","author":"Martin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0050","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2008-05-158782","article-title":"Solid cancers after allogeneic hematopoietic cell transplantation","volume":"113","author":"Rizzo","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0055","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2004-09-3411","article-title":"Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study","volume":"105","author":"Curtis","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0060","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1182\/blood-2010-07-294629","article-title":"Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning","volume":"117","author":"Majhail","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0065","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1200\/JCO.2003.05.108","article-title":"New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors","volume":"21","author":"Baker","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0070","first-page":"2208","article-title":"Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study","volume":"94","author":"Curtis","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0075","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199703273361301","article-title":"Solid cancers after bone marrow transplantation","volume":"336","author":"Curtis","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.09.005_bib9000","article-title":"National Institutes of Health hematopoietic cell transplantation late effects initiative: developing recommendations to improve survivorship and long-term outcomes","author":"Battiwalla","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/pbc.25764","article-title":"European society for blood and marrow transplantation analysis of treosulfan conditioning before hematopoietic stem cell transplantation in children and adolescents with hematological malignancies","volume":"63","author":"Boztug","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0085","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/bmt.2015.43","article-title":"Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up","volume":"50","author":"Wilhelmsson","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0090","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/leu.2014.203","article-title":"Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy","volume":"29","author":"Nelson","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0095","doi-asserted-by":"crossref","DOI":"10.1038\/bmt.2016.135","article-title":"The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia","author":"Gifford","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/bjc.2014.523","article-title":"Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study","volume":"112","author":"Chien","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1179\/1607845414Y.0000000154","article-title":"Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction","volume":"19","author":"Zamora-Ortiz","year":"2014","journal-title":"Hematology"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0110","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.bbmt.2014.07.009","article-title":"Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning","volume":"20","author":"Ringden","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0115","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.1179.1179","article-title":"Incidence of secondary malignancies following allogeneic hematopoietic cell transplantation: a single center experience","volume":"124","author":"Michelis","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/imj.12336","article-title":"Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study","volume":"44","author":"Gifford","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/bmt.2012.166","article-title":"Second malignancies after autologous hematopoietic cell transplantation in children","volume":"48","author":"Danner-Koptik","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/2193-1801-2-424","article-title":"Eleven secondary cancers after hematopoietic stem cell transplantation using a total body irradiation-based regimen in 370 consecutive pediatric and adult patients","volume":"2","author":"Omori","year":"2013","journal-title":"Springerplus"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0135","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","article-title":"Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study","volume":"19","author":"Sun","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0140","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/j.ijrobp.2012.07.415","article-title":"Total body irradiation in very young children","volume":"84","author":"Yang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0145","first-page":"721","article-title":"Secondary cancers following stem cell transplantation: a single center experience","volume":"97","author":"Muftuoglu","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0150","first-page":"S351","article-title":"Malignancies after allogeneic haematopoietic stem cell transplantation-a single-centre analysis of 370 patients","volume":"47","author":"Kauppila","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0155","article-title":"Impact of comorbidities on early and late mortalities after allogeneic Hematopoietic Cell Transplantation (HCT)","volume":"118","author":"Sorror","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0160","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V118.21.4100.4100","article-title":"Long-term complications (LTC) and quality of life (QOL) after reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT)","volume":"118","author":"Clavert","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0165","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0609.2011.01638.x","article-title":"Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation","volume":"87","author":"Bieri","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0170","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1016\/j.bbmt.2010.12.070","article-title":"Risk and risk factors of secondary solid cancers after allogeneic hematopoietic stem cell transplantation in adult recipients","volume":"17","author":"Atsuta","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0175","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.2353.2353","article-title":"Phase II prospective multicenter study of treosulfan based reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for hematological malignancies from 10\/10 hla identical unrelated donor","volume":"116","author":"Michallet","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0180","first-page":"S96","article-title":"The incidence of secondary malignancy post stem cell transplantation: importance of conditioning regimens without total body irradiation","volume":"45","author":"Ghavamzadeh","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0185","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(09)70352-3","article-title":"Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial","volume":"11","author":"Friedrichs","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0190","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.bbmt.2010.02.014","article-title":"Donor-derived second hematologic malignancies after cord blood transplantation","volume":"16","author":"Ballen","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0195","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/bmt.2009.128","article-title":"Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens","volume":"45","author":"Abou-Mourad","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"suppl 2","key":"10.1016\/j.bbmt.2016.09.005_bib0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00066-009-1008-x","article-title":"Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies","volume":"185","author":"Ricardi","year":"2009","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0205","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1200\/JCO.2001.19.2.464","article-title":"Solid cancers after bone marrow transplantation","volume":"19","author":"Bhatia","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0210","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.bmt.1702148","article-title":"Melphalan\/TBI is not more carcinogeneic than cyclophosphamide\/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years","volume":"25","author":"Kulkarni","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0215","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-131-10-199911160-00004","article-title":"Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group","volume":"131","author":"Kolb","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0220","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1200\/JCO.1994.12.10.2187","article-title":"Secondary malignancies after bone marrow transplantation in adults","volume":"12","author":"Lowsky","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bmt.1704706","article-title":"Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation","volume":"35","author":"Hasegawa","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0230","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2006.08.9276","article-title":"Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study","volume":"25","author":"Cohen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0235","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.bmt.1704674","article-title":"Nonhematologic malignancies after allogeneic hematopoietic stem cell transplantation: incidence and molecular monitoring","volume":"34","author":"Au","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0240","first-page":"969","article-title":"Development of leukemia in donor cells after allogeneic stem cell transplantation\u2013a survey of the European Group for Blood and Marrow Transplantation (EBMT)","volume":"90","author":"Hertenstein","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0245","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3109\/10428194.2014.951846","article-title":"Outcome of pediatric patients with lymphoma following stem cell transplant: a single institution report","volume":"56","author":"Sumaili","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0250","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjh.13174","volume":"168","author":"Kato","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0255","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.bbmt.2013.12.171","article-title":"Long term outcomes of autologous hematopoietic cell transplant (AHCT) following thiotepa-based high-dose therapy (HDT) in patients with non-Hodgkin lymphoma (NHL)","volume":"20","author":"Shah","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0260","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.4636.4636","article-title":"Secondary malignancies after autologous stem cell transplantation in patients with relapsed\/refractory Hodgkin's lymphoma. A retrospective analysis on behalf of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)","volume":"122","author":"Sureda","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0265","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbmt.2012.10.029","article-title":"Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome","volume":"19","author":"Nieto","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.achaem.2013.07.278","article-title":"Second malignancies after autologous hematopoietic stem cell transplantation following a uniform conditioning regimen in patients with lymphoma-characteristics and risk factors analysis","volume":"44","author":"Czyz","year":"2013","journal-title":"Acta Haematol Pol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0275","doi-asserted-by":"crossref","first-page":"S289","DOI":"10.1016\/S0959-8049(11)71297-7","article-title":"Hematopoietic stem cell transplantation with total body irradiation conditioning in childhood acute lymphoblastic leukemia patients with relapsed or high risk group","volume":"47","author":"Kim","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0280","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3109\/10428194.2010.486090","article-title":"Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience","volume":"51","author":"Viviani","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0285","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.688.688","article-title":"Is there still a place for total body irradiation (TBI) in the conditioning regimen of autologous stem cell transplantation in mantle cell lymphoma ?: a retrospective study from the Lymphoma Working Party of the EBMT","volume":"116","author":"Rubio","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0290","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V114.22.3406.3406","article-title":"Autologous hematopoietic stem cell transplantation following a uniform modified BEAM conditioning regimen for Hodgkin's lymphoma\u2014prognostic factors and long-term outcomes","volume":"114","author":"Czyz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0295","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/10428190109097649","article-title":"Incidence of post transplant myelodysplasia\/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV)","volume":"40","author":"Wheeler","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0300","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2001.19.5.1395","article-title":"Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas\/Transplante Autologo de Medula Osea Spanish Cooperative Group","volume":"19","author":"Sureda","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0305","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.bmt.1702510","article-title":"Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignancies","volume":"26","author":"Park","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0310","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1182\/blood.V95.5.1588.005k38_1588_1593","article-title":"Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors","volume":"95","author":"Krishnan","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0315","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood.V84.3.957.957","article-title":"Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma","volume":"84","author":"Traweek","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0320","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.bbmt.2014.12.028","article-title":"New cancers after autotransplantations for multiple myeloma","volume":"21","author":"Mahindra","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0325","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/j.clml.2015.07.437","article-title":"Secondary malignancies in multiple myeloma","volume":"15","author":"Vadikoliou","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0330","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.3366.3366","article-title":"Characteristics of multiple myeloma patients with 6-year or longer progression-free survival after a single autologous transplant","volume":"122","author":"Adekola","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0335","first-page":"S274","article-title":"Outcome of allogeneic hematopoietic stem cell transplantation in pediatric patients with acquired severe aplastic anemia: a Turkish multicenter study","volume":"50","author":"Ko\u00e7ak","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0340","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3324\/haematol.2014.106096","article-title":"Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"99","author":"Dufour","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0345","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2013-01-479733","article-title":"Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience","volume":"122","author":"Peffault de Latour","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0350","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3324\/haematol.2011.050096","article-title":"Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning","volume":"97","author":"Konopacki","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0355","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.bbmt.2012.06.018","article-title":"Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research","volume":"18","author":"Buchbinder","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0360","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbmt.2007.06.015","article-title":"Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen","volume":"14","author":"Inamoto","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0365","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V87.1.386.386","article-title":"Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients","volume":"87","author":"Deeg","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0370","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJM199310143291603","article-title":"Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party","volume":"329","author":"Socie","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0375","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1182\/blood-2003-07-2546","article-title":"Long-term outcome after bone marrow transplantation for severe aplastic anemia","volume":"103","author":"Ades","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0380","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bbmt.2016.03.007","article-title":"Long-term survival, organ function, and malignancy after hematopoietic stem cell transplantation for Fanconi anemia","volume":"22","author":"Bonfim","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0385","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bbmt.2016.01.027","article-title":"Second cancer risk and late mortality in adult Australians receiving allogeneic hematopoietic stem cell transplantation: a population-based cohort study","volume":"22","author":"Vajdic","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0390","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamadermatol.2015.3902","article-title":"Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study","volume":"152","author":"Omland","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0395","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1200\/JCO.2005.02.7052","article-title":"Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation","volume":"24","author":"Leisenring","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0400","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","article-title":"Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0405","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3324\/haematol.11034","article-title":"Therapy-related leukemia and myelodysplasia: susceptibility and incidence","volume":"92","author":"Leone","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0410","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1182\/blood-2002-04-1261","article-title":"Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study","volume":"101","author":"Metayer","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0415","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1365-2141.1999.01627.x","article-title":"Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation","volume":"106","author":"Milligan","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0420","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0425","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3324\/haematol.2011.053363","article-title":"Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantation","volume":"97","author":"Melenhorst","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0430","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2016.01.003","article-title":"Homeostatic cytokines in immune reconstitution and graft-versus-host disease","volume":"82","author":"Thiant","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0435","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/00007890-200109150-00040","article-title":"T-cell lymphoma with eosinophilia of donor origin occurring 12 years after allogeneic bone marrow transplantation for myeloma","volume":"72","author":"Rivet","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0440","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1309\/VA755A03PVRV9XDT","article-title":"T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation","volume":"120","author":"Au","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0445","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1309\/GLH5NVCFB9BKMV9G","article-title":"T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disorders","volume":"123","author":"Chang","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0450","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/bjd.12647","article-title":"Development of mycosis fungoides after bone marrow transplantation for chronic myeloid leukaemia: transmission from an allogeneic donor","volume":"170","author":"Fahy","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0455","doi-asserted-by":"crossref","first-page":"e855","DOI":"10.1200\/JCO.2011.37.7101","article-title":"Donor-derived lymphomatoid papulosis in a stem-cell transplantation recipient","volume":"29","author":"Camp","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0460","doi-asserted-by":"crossref","first-page":"e778","DOI":"10.1111\/j.1365-2230.2009.03509.x","article-title":"Primary cutaneous T-cell lymphoproliferative disorder of donor origin after allogeneic haematopoietic stem-cell transplantation","volume":"34","author":"Santos-Briz","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0465","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0470","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/leu.2014.132","article-title":"Risk of myeloid neoplasms after solid organ transplantation","volume":"28","author":"Morton","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0475","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/tid.12367","article-title":"Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients","volume":"17","author":"Wojenski","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0480","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3816\/CLM.2007.n.031","article-title":"T-cell large granular lymphocyte leukemia of donor origin after cord blood transplantation","volume":"7","author":"Kusumoto","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0485","first-page":"186869","article-title":"Donor cell myeloid sarcoma in an umbilical cord transplant patient: a case report and a review of the literature","volume":"2015","author":"Hayes","year":"2015","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0490","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ajh.20349","article-title":"Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma","volume":"79","author":"Matsunaga","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0495","doi-asserted-by":"crossref","first-page":"E241","DOI":"10.1111\/j.1399-3046.2011.01584.x","article-title":"Donor cell-derived acute myeloid leukemia after second allogenic cord blood transplantation in a patient with Fanconi anemia","volume":"16","author":"Gustafsson","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0500","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1182\/blood-2005-06-2551","article-title":"First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation","volume":"106","author":"Fraser","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0505","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/bmt.2013.127","article-title":"Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source","volume":"49","author":"Shiozaki","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0510","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/14653240701466339","article-title":"Four cases of donor cell-derived AML following unrelated cord blood transplantation for adult patients: experiences of the Tokyo Cord Blood Bank","volume":"9","author":"Nagamura-Inoue","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0515","first-page":"6751914","article-title":"A 54-year-old woman with donor cell origin of multiple myeloma after allogeneic hematopoietic stem cell transplantation for the treatment of CML","volume":"2016","author":"Maestas","year":"2016","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0520","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.exphem.2011.09.002","article-title":"Recurrence of monoclonal gammopathy associated with donor-derived myelodysplastic syndrome after cord blood stem cell transplantation","volume":"39","author":"Yamazaki","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0525","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jcp.2010.084731","article-title":"Donor cell origin of multiple myeloma occurring after allogeneic haematopoietic stem cell transplantation in a patient with refractory anaemia with ring sideroblast","volume":"64","author":"Kim","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0530","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1046\/j.1365-2141.2000.01913.x","article-title":"IgA myeloma of donor origin arising 7 years after allogeneic renal transplant","volume":"108","author":"Grey","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0535","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cancergen.2015.10.003","article-title":"Transmission of an expanding donor-derived del(20q) clone through allogeneic hematopoietic stem cell transplantation without the development of a hematologic neoplasm","volume":"208","author":"Aikawa","year":"2015","journal-title":"Cancer Genet"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0540","first-page":"38","article-title":"Acute myeloid leukemia arising from a donor derived premalignant hematopoietic clone: a possible mechanism for the origin of leukemia in donor cells","volume":"3","author":"Dickson","year":"2014","journal-title":"Leuk Res Rep"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0545","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/bmt.2011.256","article-title":"Successful use of second cord blood transplantation to achieve long-term remission in cord blood donor cell-derived AML harboring a FLT3-ITD and an NPM1 mutation","volume":"47","author":"Chonabayashi","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0550","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.humpath.2013.01.001","article-title":"Mutation of the NPM1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia","volume":"44","author":"Rodriguez-Macias","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0555","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/leu.2013.278","article-title":"Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation","volume":"28","author":"Yasuda","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0560","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1182\/blood-2008-03-077974","article-title":"Graft-versus-leukemia effects of transplantation and donor lymphocytes","volume":"112","author":"Kolb","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0565","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.bmt.1701923","article-title":"Telomere length changes in patients undergoing hematopoietic stem cell transplantation","volume":"24","author":"Lee","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0570","doi-asserted-by":"crossref","first-page":"13782","DOI":"10.1073\/pnas.94.25.13782","article-title":"In vivo telomere dynamics of human hematopoietic stem cells","volume":"94","author":"Notaro","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0575","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1634\/stemcells.2007-0409","article-title":"Donor-derived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation","volume":"25","author":"Avital","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0580","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/PAS.0b013e318261089c","article-title":"Carcinoma of donor origin after allogeneic peripheral blood stem cell transplantation","volume":"36","author":"Munakata","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0585","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2008-07-171702","article-title":"Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation","volume":"113","author":"Janin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0590","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1111\/j.1600-6143.2006.01581.x","article-title":"A solid tumor of donor cell-origin after allogeneic peripheral blood stem cell transplantation","volume":"6","author":"Arai","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0595","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.exphem.2009.09.008","article-title":"Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemia","volume":"37","author":"Shirai","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0600","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/scd.2010.0593","article-title":"Analyses of donor-derived keratinocytes in hairy and nonhairy skin biopsies of female patients following allogeneic male bone marrow transplantation","volume":"21","author":"Nemeth","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0605","doi-asserted-by":"crossref","first-page":"e79615","DOI":"10.1371\/journal.pone.0079615","article-title":"Bone marrow-derived cells may not be the original cells for carcinogen-induced mouse gastrointestinal carcinomas","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0610","first-page":"283","article-title":"The origin of epithelial neoplasms after allogeneic stem cell transplantation","volume":"91","author":"Smith","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0615","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejcsup.2014.05.001","article-title":"Current knowledge and future research directions in treatment-related second primary malignancies","volume":"12","author":"Morton","year":"2014","journal-title":"EJC Suppl"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0620","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1470-2045(08)70286-9","article-title":"A review of human carcinogens-Part A: pharmaceuticals","volume":"10","author":"Grosse","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0625","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1667\/RR1469.1","article-title":"Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation","volume":"171","author":"Schwartz","year":"2009","journal-title":"Radiat Res"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0630","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bmt.1705531","article-title":"Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors","volume":"38","author":"Hows","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0635","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1038\/sj.bmt.1704854","article-title":"Secondary malignancies and quality of life after stem cell transplantation","volume":"35","author":"Ortega","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0640","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1200\/JCO.2003.05.108","article-title":"New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors","volume":"21","author":"Baker","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0645","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-131-10-199911160-00004","article-title":"Malignant neoplasms in long-term survivors of bone marrow transplantation","volume":"131","author":"Kolb","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0650","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMoa1114083","article-title":"Lenalidomide after stem-cell transplantation for multiple myeloma","volume":"366","author":"McCarthy","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0655","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1056\/NEJMoa1114138","article-title":"Lenalidomide maintenance after stem-cell transplantation for multiple myeloma","volume":"366","author":"Attal","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0660","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa1402888","article-title":"Autologous transplantation and maintenance therapy in multiple myeloma","volume":"371","author":"Palumbo","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0665","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S1470-2045(15)00389-7","article-title":"Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial","volume":"16","author":"Gay","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0670","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1470-2045(13)70609-0","article-title":"Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data","volume":"15","author":"Palumbo","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0675","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1182\/blood-2012-04-421883","article-title":"Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance","volume":"120","author":"Usmani","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0680","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bbmt.2012.09.023","article-title":"Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma","volume":"19","author":"Krishnan","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0685","doi-asserted-by":"crossref","first-page":"S653","DOI":"10.1016\/S0959-8049(16)31791-9","article-title":"Second solid cancers after total body irradiation conditioning in children undergoing hematopoietic stem cell transplant","volume":"51","author":"Lee","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0690","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.15_suppl.6548","article-title":"Second cancers after hematopoietic stem cell transplantation with total body irradiation conditioning regimen in hematologic disorders","volume":"29","author":"Kim","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0695","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bmt.2011.23","article-title":"Secondary solid tumors after allogeneic hematopoietic SCT in Japan","volume":"47","author":"Yokota","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0700","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/annonc\/mdt558","article-title":"Continuing increased risk of oral\/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease","volume":"25","author":"Atsuta","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0705","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bmt.1705020","article-title":"Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis","volume":"36","author":"Shimada","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0710","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/leu.2012.299","article-title":"Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced","volume":"27","author":"Shimoni","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0715","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1182\/blood-2004-04-1652","article-title":"Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants","volume":"105","author":"Rosenberg","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0720","doi-asserted-by":"crossref","first-page":"11592","DOI":"10.1073\/pnas.191211198","article-title":"Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia","volume":"98","author":"Allan","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0725","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.leu.2403947","article-title":"Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients","volume":"19","author":"Rund","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0730","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1568-7864(03)00020-X","article-title":"Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome","volume":"2","author":"Casorelli","year":"2003","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0735","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.leu.2402747","article-title":"Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia","volume":"17","author":"Seedhouse","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0740","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood.V94.2.733","article-title":"Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia","volume":"94","author":"Zhu","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0745","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/sj.leu.2401466","article-title":"Distinct genetic involvement of the TP53 gene in therapy-related leukemia and myelodysplasia with chromosomal losses of Nos 5 and\/or 7 and its possible relationship to replication error phenotype","volume":"13","author":"Horiike","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0750","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1158\/1078-0432.CCR-03-0372","article-title":"Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia","volume":"10","author":"Seedhouse","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0755","first-page":"604","article-title":"Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans","volume":"58","author":"Shen","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0760","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/carcin\/22.9.1437","article-title":"XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects","volume":"22","author":"Matullo","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0765","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1289\/ehp.6632","article-title":"Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays","volume":"111","author":"Au","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0770","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2004-06-2161","article-title":"Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy","volume":"104","author":"Allan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0775","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1182\/blood-2007-11-126508","article-title":"MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility","volume":"112","author":"Ellis","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0780","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1182\/blood-2008-10-183244","article-title":"Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility","volume":"113","author":"Knight","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0785","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1152\/physrev.00026.2007","article-title":"Telomeres and aging","volume":"88","author":"Aubert","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0790","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1586\/ehm.13.23","article-title":"Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders","volume":"6","author":"Ballew","year":"2013","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0795","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1017\/S146239941000147X","article-title":"Variation at the TERT locus and predisposition for cancer","volume":"12","author":"Baird","year":"2010","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0800","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00439-012-1212-0","article-title":"Genome-wide association study of glioma and meta-analysis","volume":"131","author":"Rajaraman","year":"2012","journal-title":"Hum Genet"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0805","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1158\/1055-9965.EPI-11-0005","article-title":"The association of telomere length and cancer: a meta-analysis","volume":"20","author":"Wentzensen","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0810","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.2010.897","article-title":"Telomere length and risk of incident cancer and cancer mortality","volume":"304","author":"Willeit","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0815","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2011.06.004","article-title":"Telomere biology in hematopoiesis and stem cell transplantation","volume":"25","author":"Gadalla","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0820","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood-2009-03-209833","article-title":"Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sex","volume":"114","author":"Baerlocher","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0825","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1182\/blood-2012-01-403337","article-title":"Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation","volume":"120","author":"Peffault de Latour","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0830","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jama.2015.7","article-title":"Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia","volume":"313","author":"Gadalla","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0835","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.2008.17.1033","article-title":"Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma","volume":"27","author":"Chakraborty","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0840","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1470-2045(09)70326-2","article-title":"A review of human carcinogens\u2013Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish","volume":"10","author":"Secretan","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0845","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2013Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0850","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1470-2045(09)70213-X","article-title":"A review of human carcinogens\u2013part D: radiation","volume":"10","author":"El Ghissassi","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0855","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jncimonographs\/lgu013","article-title":"Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Morton","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0860","doi-asserted-by":"crossref","first-page":"E148","DOI":"10.1111\/tid.12098","article-title":"Human papillomavirus reactivation following treatment of genital graft-versus-host disease","volume":"15","author":"Sri","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0865","series-title":"European Society for Blood and Marrow Transplantation Annual Meeting","article-title":"Genital human papillomavirus (HPV) reactivation patterns in female allotransplant survivors support HPV vaccination","author":"Battiwalla","year":"2016"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0870","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1034\/j.1600-0714.2002.310302.x","article-title":"Comparison of HPV infection, p53 mutation and allelic losses in post-transplant and non-posttransplant oral squamous cell carcinomas","volume":"31","author":"Zhang","year":"2002","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0875","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.oraloncology.2005.02.001","article-title":"Oral malignancies following HSCT: graft versus host disease and other risk factors","volume":"41","author":"Demarosi","year":"2005","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1524-4725.2012.02558.x","article-title":"Cutaneous squamous cell carcinoma and human papillomavirus: is there an association?","volume":"39","author":"Aldabagh","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0885","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1158\/1078-0432.CCR-08-3099","article-title":"Can routine posttransplant HPV vaccination prevent commonly occurring epithelial cancers after allogeneic stem cell transplantation?","volume":"15","author":"Savani","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0890","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0895","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/bmt.2013.96","article-title":"EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT","volume":"49","author":"Rasche","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0900","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1053\/j.gastro.2005.10.011","article-title":"Epstein-Barr virus-related gastric adenocarcinoma: an early secondary cancer post hemopoietic stem cell transplantation","volume":"129","author":"Au","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0905","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1182\/blood-2013-02-487652","article-title":"Transient proliferation of donor-derived ATL cell-like lymphocytes early after allogeneic stem cell transplantation in an adult T-cell leukemia\/lymphoma patient","volume":"121","author":"Taguchi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0910","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.chom.2010.05.006","article-title":"Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin","volume":"7","author":"Schowalter","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0915","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.14694\/EdBook_AM.2015.35.e519","article-title":"Merkel cell carcinoma: emerging biology, current approaches, and future directions","author":"Tothill","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0920","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbmt.2014.03.006","article-title":"A population-based cohort study of late mortality in adult autologous hematopoietic stem cell transplant recipients in Australia","volume":"20","author":"Ashton","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0925","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/10428199209049797","article-title":"Poor clinical outcome of patients developing malignant solid tumors after bone marrow transplantation for severe aplastic anemia","volume":"7","author":"Socie","year":"1992","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0930","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1200\/JCO.1999.17.10.3128","article-title":"Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma","volume":"17","author":"Friedberg","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0935","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/ajcp\/107.4.419","article-title":"Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features","volume":"107","author":"Orazi","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0940","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bmt.1704124","article-title":"Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma","volume":"32","author":"Howe","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0945","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1365-2362.2008.02041.x","article-title":"Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation","volume":"38","author":"Boehm","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0950","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/bmt.2015.203","article-title":"Survival of patients who develop solid tumors following hematopoietic stem cell transplantation","volume":"51","author":"Ehrhardt","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0955","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nrclinonc.2012.111","article-title":"T-cell therapy in the treatment of post-transplant lymphoproliferative disease","volume":"9","author":"Bollard","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0960","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1111\/ajt.12475","article-title":"Rapid generation of EBV-specific cytotoxic T lymphocytes resistant to calcineurin inhibitors for adoptive immunotherapy","volume":"13","author":"Ricciardelli","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0965","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/bmt.2012.5","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"47","author":"Majhail","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0970","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbmt.2012.01.003","volume":"18","author":"Pulsipher","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0975","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbmt.2005.09.012","volume":"12","author":"Rizzo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0980","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbmt.2016.01.023","article-title":"Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a Children's Oncology Group report","volume":"22","author":"Chow","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0985","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/bmt.2015.63","article-title":"Secondary solid cancer screening following hematopoietic cell transplantation","volume":"50","author":"Inamoto","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0990","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbmt.2010.10.023","article-title":"Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors","volume":"17","author":"Khera","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib0995","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbmt.2009.09.015","article-title":"The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls","volume":"16","author":"Bishop","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib1000","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/bmt.2011.60","article-title":"Health behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation (HCT): a report from the BMT Survivor Study","volume":"47","author":"Armenian","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.09.005_bib1005","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1200\/JCO.2005.01.230","article-title":"Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer","volume":"23","author":"Demark-Wahnefried","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.09.005_bib1010","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1200\/JCO.2006.06.6340","article-title":"Provider counseling about health behaviors among cancer survivors in the United States","volume":"25","author":"Sabatino","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116303317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116303317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:57:15Z","timestamp":1761058635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879116303317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":202,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1083879116303317"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.09.005","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}